• Synagistics posted a net loss of SGD 17.5 million, narrowing from SGD 28.8 million a year earlier.
• Revenue rose 11.6% to SGD 39.8 million, with D2B up 10.9% to SGD 13.9 million.
• D2C climbed 11.9% to SGD 25.9 million; gross profit increased 5.4% to SGD 9.9 million.
• Adjusted EBITDA (non-IFRS) was a loss of SGD 3.8 million, compared with a loss of SGD 2.3 million.
• Geene 2.0 was unveiled on July 22, 2026, with a public launch planned for Aug. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Synagistics Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12305313), on August 28, 2026, and is solely responsible for the information contained therein.